SM
Shin-ichi Muramatsu, M.D., Ph.D.
Board Director, Visiting Professor of Jichi Medical University
OnoderaTherapeutic Areas
Onodera Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Gene Therapy for Sporadic ALS | Amyotrophic Lateral Sclerosis (Sporadic) | Preclinical |
| Gene Therapy for Parkinson's | Parkinson's Disease | Preclinical |